Research Papers:
A greater number of dissected lymph nodes is associated with more favorable outcomes in bladder cancer treated by radical cystectomy: a meta-analysis
Metrics: PDF 2360 views | HTML 2428 views | ?
Abstract
Fei Li1,*, Xuwei Hong1,*, Lina Hou2,*, Fengsheng Lin1, Pengliang Chen1, Shiyu Pang1, Yuejun Du1,*, He Huang3,*, Wanlong Tan1,*
1Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P. R. China
2Department of Healthy Management, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P. R. China
3Department of Urology, The Third People's Hospital of Hubei Province, Wuhan, Hubei 430415, P. R. China
*These authors contributed equally to this work
Correspondence to:
Wanlong Tan, email: [email protected]
He Huang, email: [email protected]
Yuejun Du, email: yunjun [email protected]
Keywords: bladder cancer, lymph node dissection, radical cystectomy, outcome, meta-analysis
Received: April 17, 2016 Accepted: August 10, 2016 Published: August 17, 2016
ABSTRACT
The optimal extent of lymph node dissection (LND) is currently not established, and the debate regarding the association between the number of dissected nodes and the outcomes of bladder cancer treated by radical cystectomy (RC) is still ongoing. Therefore, the present meta-analysis was performed to clarify this potential relationship. Eligible studies were retrieved via an electronic search for studies published up to April 2016, and by manual review of the references. A total of 25 cohort studies involving 41,400 bladder cancer patients who underwent RC were included. The summary relative risk estimates (SRRE) based on the highest compared with the lowest categories of LND were estimated by variance-based meta-analysis. Heterogeneity among the study results was explored through stratified analyses. Overall, bladder cancer patients with the highest category of LND had 28%, 34% and 36% reduced risks, corresponding to overall survival (SRRE = 0.72; 95% CI, 0.64–0.80), cancer-specific survival (SRRE = 0.66; 95% CI, 0.54–0.80) and recurrence-free survival (SRRE = 0.64; 95% CI, 0.50–0.82), respectively, compared with patients with the lowest category of LND. In summary, the patients with a greater number of dissected lymph nodes had statistically significant survival advantages in terms of the outcomes of bladder cancer following RC. The number of dissected lymph nodes could be an independent prognostic factor for bladder cancer. These findings need to be validated in prospective and larger epidemiological studies with a longer follow-up period.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11343